股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 重新提交 致：香港交易及結算所有限公司 公司名稱: 上海重塑能源集團股份有限公司 (「本公司」) 呈交日期: 2026年2月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02570 | 說明 | H股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 57,613,535 | RMB | | 1 | RMB | | 57,613,535 | | 增加 / 減少 (-) | | | 4,536,000 | | | | RMB | | 4,536,000 | | 本月底結存 | | | 62,149,535 | RMB | | 1 | RMB | | 6 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 上海重塑能源集團股份有限公司 (「本公司」) 呈交日期: 2026年2月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | H | | | 於香港聯交所上市 (註1) | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 02570 | 說明 | H股 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 57,613,535 | RMB | | 1 | RMB | | 57,613,535 | | 增加 / 減少 (-) | | | 4,536,000 | | | | RMB | | 4,536,000 | | 本月底結存 | | | 62,149,535 | RMB | | 1 | RMB | | 62 ...

Group 1 - A total of 78 stocks reached a 52-week high as of February 3, with notable performers including Asia Pacific Financial Investments (08193) at 57.14%, Chao Wei Holdings (08059) at 36.00%, and Asia Backup (08290) at 33.33% [1] - The closing prices for the top three stocks that reached new highs were 0.550, 0.052, and 0.024 respectively, with their highest prices being 0.550, 0.068, and 0.036 [1] - Other significant stocks that reached new highs include Huameilele (08429) with a high rate of 20.37% and Haode Holdings (08149) at 17.65% [1] Group 2 - The report also lists stocks that reached 52-week lows, with the worst performer being Gaodi Holdings (01676) at -10.00%, followed by Huajian Medical (01931) at -9.29% and Electronic Trading Group (08036) at -9.09% [3] - The closing prices for the stocks that reached new lows include 0.340, 1.280, and 0.021 respectively, with their lowest prices being 0.315, 1.270, and 0.020 [3] - Other notable stocks that reached new lows include Controllon (01912) at -8.93% and Cool Link (08491) at -8.11% [3]

Group 1 - The stock of ReNew Energy (02570.HK) fell nearly 9%, reaching a historical low of 48.06 HKD [2] - As of the report, ReNew Energy was down 8.67%, trading at 48.22 HKD, with a trading volume of 54.848 million HKD [2] - The total market capitalization of ReNew Energy is now below 5 billion HKD [2]

Core Viewpoint - Reshape Energy (02570) has seen a significant decline in its stock price, reaching a historical low of 48.06 HKD, with a market capitalization of less than 5 billion HKD [1] Group 1: Stock Performance - The stock dropped nearly 9%, trading at 48.22 HKD with a trading volume of 54.848 million HKD [1] - The decline reflects investor concerns, as the company’s market value has fallen below 5 billion HKD [1] Group 2: Recent Announcements - Reshape Energy announced the completion of a placement of 4.536 million shares, raising a net amount of 258 million HKD [1] - 50% of the raised funds are intended for repaying bank loans and lease liabilities, while the remainder will be used for general corporate purposes [1] Group 3: Industry Insights - Reshape Energy is recognized as a leader in fuel cells, with expectations of rapid technological advancements and cost reductions in the sector [1] - According to CICC, the total lifecycle cost of fuel cell heavy trucks is anticipated to reach parity gradually after 2028 [1]

Company News - China Power (02380.HK) expects a total consolidated electricity sales volume of 10.73105 million MWh by December 2025, a decrease of 2.31% year-on-year; the total annual electricity sales volume is approximately 126 million MWh, down 1.27% year-on-year [2] - Harbin Electric (01133.HK) anticipates a net profit attributable to shareholders of approximately RMB 2.65 billion for the fiscal year 2025, compared to RMB 1.686 billion in the previous year, mainly due to increased operating revenue and improved product profitability [2] - Singularity Guofeng (01280.HK) has entered into a GPU distribution cooperation agreement with Muxi Co., aiming to enter the domestic AI computing power market [2] - Dongyang Sunshine Pharmaceutical (06887.HK) has signed a strategic cooperation agreement with Shenzhen Jingtai to establish a joint venture for building an AI-driven drug research and development platform [2] - Weisheng Pharmaceutical-B (02561.HK) has received approval from the National Medical Products Administration for the marketing authorization application of injectable Long Pei growth hormone [2] - Kintor Pharmaceutical-B (02171.HK) issued a profit warning, expecting a net loss for 2025 to be reduced to no more than approximately RMB 120 million [2] - Zhaoke Ophthalmology-B (06622.HK) is advancing the commercialization process of BRIMOCHOL PF for treating presbyopia in Singapore and Vietnam through partnerships with AFT and Qianshou [2] Additional Company Developments - Heng Rui Medicine (01276.HK) has received a clinical trial approval notice for SHR-1049 injection [3] - Baolong Real Estate (01238.HK) has had its bond restructuring plan approved by the relevant bondholders' meeting [3] Strategic Partnerships - Yabo Technology Holdings (08279.HK) has entered into a technical service agreement with Hong Kong Gold Exchange Limited [4] - Future Data Group (08229.HK) has signed a strategic cooperation framework agreement with Linghe Culture [4] - Howey Group (00501.HK) plans to invest up to USD 50 million to subscribe for shares in Aixin Yuanzhi's initial public offering [4] Buyback Activities - Xiaomi Group-W (01810.HK) repurchased 3.9872 million shares for HKD 140 million, with a repurchase price ranging from HKD 35.04 to HKD 35.22 [5] - China Metallurgical Group (01618.HK) repurchased 9.011 million shares for HKD 16.9299 million, with a repurchase price of HKD 1.87 to HKD 1.88 [5] - Geely Automobile (00175.HK) repurchased 4.401 million shares for HKD 72.952 million, with a repurchase price ranging from HKD 16.43 to HKD 16.65 [6] - Reshape Energy (02570.HK) completed the placement of a total of 4.536 million placement shares, raising approximately HKD 258 million [6] - Kintor Pharmaceutical-B (09939.HK) saw an increase of 4.7 million shares by Chairman Tong Youzhi [6]

Core Viewpoint - The company has successfully completed a placement agreement, raising approximately HKD 265 million through the issuance of 4.536 million shares at a price of HKD 58.38 per share, with the net proceeds expected to be fully utilized by December 31, 2026 [1] Group 1 - The placement involved the issuance of 4.536 million shares, representing about 7.88% of the company's issued H shares and approximately 5.12% of the total issued shares prior to the placement [1] - After the placement, the issued H shares will increase, resulting in approximately 7.30% of the enlarged issued H shares and about 4.87% of the enlarged total issued shares [1] - The total gross proceeds from the placement are approximately HKD 265 million, with net proceeds estimated at HKD 258 million after deducting commissions and related costs [1] Group 2 - The company plans to allocate the net proceeds as follows: approximately 50% or HKD 129 million will be used to optimize the financial structure by repaying outstanding bank loans and lease liabilities, and the remaining 50% or HKD 129 million will be used for general corporate purposes [1] - The expected full utilization of the net proceeds is anticipated by December 31, 2026 [1]

Group 1 - The core point of the article is that Zhongshun Energy (02570.HK) has successfully completed a placement agreement, with the delivery occurring on January 26, 2026 [1] - The placement agent has sold a total of 4.536 million shares at a price of HKD 58.38 per share to no fewer than six subscribers [1] - The total amount raised from the placement is approximately HKD 264.8 million, with a net amount of approximately HKD 258.4 million [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 上海重塑能源集團股份有限公司 呈交日期： 2026年1月26日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | H | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02570 | 說明 | H股 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | 事件 | | 已發行股份（不包括庫存股份）數 目 | ...

Core Viewpoint - The company, 重塑能源 (02570), has successfully completed a placement agreement, with the delivery executed on January 26, 2026, raising approximately HKD 265 million in total proceeds [1] Group 1: Placement Details - The placement involved the successful sale of 4.536 million shares at a price of HKD 58.38 per share, representing about 7.88% of the company's issued H shares prior to the placement [1] - After the issuance of the placement shares, the total issued H shares will increase, resulting in approximately 7.30% of the newly issued H shares and about 4.87% of the total issued shares [1] Group 2: Financial Impact - The total proceeds from the placement are approximately HKD 265 million, with a net amount of about HKD 258 million after deducting commissions and related costs [1] - The net issuance price per share is approximately HKD 56.96 [1] Group 3: Use of Proceeds - The company plans to allocate approximately 50% of the net proceeds, or about HKD 129 million, to optimize its financial structure by repaying outstanding bank loans and lease liabilities [1] - The remaining 50% of the net proceeds, also around HKD 129 million, will be used for general corporate purposes [1] - The company expects to fully utilize the net proceeds by December 31, 2026 [1]